Literature DB >> 10369109

Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus.

C Houdayer1, A Lemonnier, M Gerard, C Chauve, M Tredano, T B de Villemeur, P Aymard, J P Bonnefont, D Feldmann.   

Abstract

Fragile X syndrome is the most frequent heritable genetic disease involving mental retardation and is usually caused by an expanded CGG repeat in the first exon of the FMR1 gene. Therefore, searching for CGG expansion at the FRAXA locus among the mentally retarded has become a routine investigation in neuro-paediatric practice. Consequently, we have developed a fluorescent PCR-based assay for sizing repeats as an alternative to laborious and time-consuming Southern blot. The procedure utilises a reverse fluorescent labelled primer, and the Expand Long Template PCR system (Roche) with addition of dimethylsulfoxide and 7-deaza-dGTP It allows precise determination of the CGG repeat number in males and females for alleles from normal to premutation size range and detection of full mutations in males. We believe that this PCR protocol, allowing a high sample throughput, is useful for first-line screening among mentally retarded males, possibly complemented by Southern blot analysis to assess the methylation status of large mutated alleles.

Entities:  

Mesh:

Year:  1999        PMID: 10369109     DOI: 10.1515/CCLM.1999.065

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

Review 1.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

2.  You can build it ... but will they come?: the potential "expansion" of testing methodologies for fragile X syndrome.

Authors:  Nicholas T Potter
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

3.  Clinical Utility Gene Card for: incontinentia pigmenti.

Authors:  Francesca Fusco; Alessandra Pescatore; Julie Steffann; Ghislaine Royer; Jean-Paul Bonnefont; Matilde Valeria Ursini
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

4.  An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene.

Authors:  Alessandro Saluto; Alessandro Brussino; Flora Tassone; Carlo Arduino; Claudia Cagnoli; Patrizia Pappi; Paul Hagerman; Nicola Migone; Alfredo Brusco
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

5.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Authors:  Stela Filipovic-Sadic; Sachin Sah; Liangjing Chen; Julie Krosting; Edward Sekinger; Wenting Zhang; Paul J Hagerman; Timothy T Stenzel; Andrew G Hadd; Gary J Latham; Flora Tassone
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

6.  A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

Authors:  Flora Tassone; Ruiqin Pan; Khaled Amiri; Annette K Taylor; Paul J Hagerman
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

7.  Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full-mutation alleles.

Authors:  Anders O H Nygren; Sylvia I Lens; Ralph Carvalho
Journal:  J Mol Diagn       Date:  2008-10-02       Impact factor: 5.568

8.  Betaine, dimethyl sulfoxide, and 7-deaza-dGTP, a powerful mixture for amplification of GC-rich DNA sequences.

Authors:  Marco Musso; Renata Bocciardi; Sara Parodi; Roberto Ravazzolo; Isabella Ceccherini
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

9.  An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1).

Authors:  Mahmoud S Khaniani; Paul Kalitsis; Trent Burgess; Howard R Slater
Journal:  Mol Cytogenet       Date:  2008-04-08       Impact factor: 2.009

Review 10.  Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders.

Authors:  Indhu-Shree Rajan-Babu; Samuel S Chong
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.